Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025
-
Pogacar wins final stage to seal Tour of Switzerland success
-
Henry the hero for New Zealand as England bring back Stokes
-
Bolivia removes roadblocks after emergency decree
-
Vance hopes US, Iran can turn 'new leaf' with talks
-
Europe sweats through new heatwave, with worse to come
-
Trump-backed hardliner faces leftist senator as Colombia votes
-
Japan striker Ueda channels frustration to send World Cup warning
-
Dominant Tiafoe swats aside Fritz to win Halle Open
-
France hosts street music festival despite worsening heatwave
-
India hails Sooryavanshi after record 11-ball half-century
-
Swiss US-Iran talks venue a playground of world leaders, movie stars
-
Yamal returns to kickstart Spain attack against Saudi Arabia
-
Colombians vote in presidential runoff
-
Nigerian twins Taiwo and Kehinde marry... Taiwo and Kehinde
-
Marc Marquez wins Czech MotoGP to close gap on banned Bezzecchi
-
France presses ahead with street music festival despite extreme heat
-
Marc Marquez wins Czech MotoGP as Bezzecchi banned
-
'Historical justice': Dutch PM makes formal apology to Moluccans
-
Stokes to return as England captain for 3rd New Zealand Test - McCullum
-
Henry the hero as New Zealand level England series in style
-
Britain's King Charles to reveal personal tax bill: Palace
-
Gill to skipper India against England, Kohli to play if fit
-
France presses ahead with street music festivals despite extreme heat
-
UK's Starmer mulling 'political realities': senior minister
-
England's Stokes and Atkinson withdrawn from county games ahead of 3rd Test
-
France presses ahead with music festivals despite extreme heat
-
Ukrainian strikes on Russian-annexed Crimea kill 4, pause fuel sales
-
Springboks recall 'outstanding' Papier for Nations Championship
-
US, Iran set for talks as Lebanon conflict threatens deal
-
Bezzecchi out of Czech MotoGP after slapping steward
-
Spain target convincing win to dispel World Cup doubts
-
FIFA draws criticism as Infantino clocks up air miles at World Cup
-
Curacao keeper Room jokes he deserves statue after World Cup heroics
-
Japan stroll to victory over Tunisia in World Cup's 1,000th game
-
Pakistan's mango exports shrink as Middle East war impacts linger
-
Trump blames 'terrible vandals' for Washington pool renovation woes
-
Iran World Cup travel restrictions to be eased, says coach
-
Man charged over suspected anti-Muslim attacks in Edinburgh
-
Room heroics earn Curacao World Cup point against Ecuador
-
Britain's King Charles to reveal personal tax bill: reports
-
New mindset, prior win give Clark confidence at US Open
-
Fly-half Love ready for All Blacks start after Super Rugby heroics
-
Scheffler eager to seize the moment as career slam beckons
-
Saudis seek to repeat Argentina World Cup 'miracle' against Spain
-
Clark leads by six at US Open as Scheffler charges
-
Nagelsmann says Germany has higher ambitions than advancing to knockout stage
-
Los Angeles under state of emergency due to warehouse fire
-
A Father's Love Is One of Life's Greatest Blessings - ELEKTROS Inc. Honors Fathers Around the World on Father's Day
-
To the Fathers of the World: Thank You for Your Love, Your Sacrifice, and the Light You Bring to Your Families
-
ELEKTROS Inc. Extends a Heartfelt Father's Day Blessing to Fathers Around the World
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2025
DORADO, PUERTO RICO / ACCESS Newswire / September 15, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the three and nine months ended July 31, 2025 were approximately $2.0 million and $6.9, million, respectively. Revenues for the three and nine months ended July 31, 2024 were approximately $2.4 million and $7.2 million, respectively. Net loss for the three and nine months ended July 31, 2025 was approximately $0.2 million and $0.1 million, respectively, an earnings increase of approximately $0.1 million and $0.7 million when compared to the same periods last year, respectively.
"Over the past quarters, we have taken decisive steps to streamline our cost structure, prioritize core business segments, and exit less profitable areas. We believe these efforts have positioned the Company to capitalize on new opportunities with greater agility and focus. We are encouraged by the momentum building across our operations and are preparing for the immediate commencement of several significant projects. The Company remains committed to delivering long-term value to shareholders through disciplined execution," stated Mr. Sanchez Chief Executive Officer of the Company.
About Pharma-Bio Serv, Inc.
Pharma-Bio Serv services the Puerto Rico, United States, Europe and Latin America markets. Pharma-Bio Serv's core business is FDA and international agencies regulatory compliance consulting related services. The Company's global team includes leading engineering and life science professionals, quality assurance managers and directors.
Forward-Looking Statements
This news release contains "forward-looking statements" within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the date of this earnings announcement. Although Pharma-Bio Serv's management believes these expectations, estimates, or projections to be reasonable as of the date of this earnings announcement, forward-looking statements are inherently subject to significant business risks, economic uncertainties, and competitive uncertainties, and other factors, which could cause its actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. Important factors that could cause Pharma-Bio Serv's actual results or performance to differ materially from the forward-looking statements include those set forth in the "Risk Factors" section of Pharma-Bio Serv's Annual Report on Form 10-K for the year ended October 31, 2024, and in its other filings with the Securities and Exchange Commission, which filings are available at www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.
Company Contact:
Pedro J. Lasanta
Chief Financial Officer
787 278 2709
SOURCE: Pharma-Bio Serv Inc.
View the original press release on ACCESS Newswire
H.Gonzales--AT
